Intest CORP Schedule 13G passive stakes

Askeladden Capital Management LLC and Samir Patel have filed a Schedule 13G amendment indicating they no longer beneficially own any shares of INTEST CORP common stock.

Vanguard Capital Management has reported a beneficial ownership of 4.69% in inTEST Corp's common stock as of June 30, 2026.

Vanguard Capital Management has reported a beneficial ownership of 5.45% in inTEST Corp's common stock as of March 31, 2026.

Thomas A. Satterfield, Jr. has reported a reduction in his beneficial ownership of inTest Corporation to 4.4%, falling below the 5% reporting threshold.

The Vanguard Group reported 0% beneficial ownership of inTEST Corp common stock following an internal realignment.

Thomas A. Satterfield, Jr. has increased his beneficial ownership in inTest Corporation to 8.0% of outstanding common stock.

Askeladden Capital Management LLC and Samir Patel have jointly disclosed a 5.0% beneficial ownership stake in INTEST CORP, holding 624,397 shares of common stock.

Thomas A. Satterfield, Jr. has filed an amended Schedule 13G, reporting beneficial ownership of 6.5% of inTEST Corporation's common stock as of December 31, 2024.

Investment adviser Royce & Associates LP has disclosed a beneficial ownership of 11.58% of inTEST Corporation's common stock as of December 31, 2024, held in the ordinary course of business.